Cargando…
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution
BACKGROUND: With the rapid influx of novel anti‐cancer agents, phase I clinical trials in oncology are evolving. Historically, response rates on early phase trials have been modest with the clinical benefit and ethics of enrolment debated. However, there is a paucity of real‐world data in this setti...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842700/ https://www.ncbi.nlm.nih.gov/pubmed/34245134 http://dx.doi.org/10.1002/cnr2.1465 |